Form 4 for MDT Medtronic
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-02 · accession 0001127602-21-023101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-04 | 2021-08-02 | MDT | Lerman Bradley E | SVP GC, Corp Sec | F - Tax | $131.31 | -5,450 | 42.7K | -11% | -$715.6K |
| D | 2021-08-04 | 2021-08-02 | MDT | Lerman Bradley E | SVP GC, Corp Sec | S - Sale | $131.52 | -4,000 | 48.2K | -8% | -$526.1K |
| D | 2021-08-04 | 2021-08-02 | MDT | Lerman Bradley E | SVP GC, Corp Sec | A - Grant | $0.00 | +6,019 | 48.8K | +14% | $0 |
| DM | 2021-08-04 | 2021-08-02 | MDT | Lerman Bradley E | SVP GC, Corp Sec | A - Grant | $0.00 | +67.6K | 1,085 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-02 | F | D | 5,450 | $131.31 | 42,744 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-08-02 | S | D | 4,000 | $131.52 | 48,194 | D | — | — | (F2) This balance increased by 651 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. |
| 3 | Common | Ordinary Shares | 2021-08-02 | A | A | 6,019 | $0.00 | 48,763 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | A | A | 51,423 | $0.00 | 51,423 | D | $131.26 · 2022-08-02 to 2031-08-02 | 51,423 Ordinary Shares | (F4) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 5 | Derivative | Performance Share Units | 2021-08-02 | A | A | 15,047 | $0.00 | 15,047 | D | — · — to — | 15,047 Performance Share Units | (F6) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,047 shares will be issued. The actual number of shares to be issued could range from a low of 3,010 at minimum performance to a high of 30,094 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F5) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F7) Vests on August 2, 2024. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | A | A | 1,085 | $0.00 | 1,085 | D | $131.26 · 2022-08-02 to 2031-08-02 | 1,085 Ordinary Shares | (F4) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |